Skip to main content
logo
Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
76.10
+5.65 (8.02%)
Aug 20, 2026, 4:09 PM HKT

Nanjing Leads Biolabs Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Capitalization
15,13610,143--
Market Cap Growth
1.33%---
Enterprise Value
13,7259,977--
Last Close Price
76.1051.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
76.7351.42--
PB Ratio
10.757.20--
P/TBV Ratio
10.767.21--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
69.5850.58--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.220.221.00-0.07
Net Debt / Equity Ratio
-1.00-1.00-1.020.30
Net Debt / EBITDA Ratio
7.097.091.081.15
Net Debt / FCF Ratio
7.797.792.241.37
Asset Turnover
0.140.14--
Quick Ratio
3.083.081.350.25
Current Ratio
3.373.371.500.26
Return on Equity (ROE)
-27.61%-27.61%--
Return on Assets (ROA)
-9.92%-9.92%-30.59%-
Return on Capital Employed (ROCE)
-15.20%-15.20%-100.80%27.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-1.55%-2.32%--
FCF Yield
-1.20%-1.78%--
Buyback Yield / Dilution
-16.10%-16.10%-3.56%-